| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Desmond Yap | |
| Kar Lai | |||
| P2860 | cites work | Function of the Th17/interleukin-17A immune response in murine lupus nephritis | Q85939245 |
| Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden | Q22255575 | ||
| Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of alpha-actinin | Q40271717 | ||
| Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. | Q40461845 | ||
| Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. | Q41382679 | ||
| Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells | Q41881361 | ||
| A prospective study on anti-endothelial cell antibodies in patients with systemic lupus erythematosus | Q43490054 | ||
| Severe lupus nephritis: racial differences in presentation and outcome | Q44028079 | ||
| MHC class I expression regulates susceptibility to spontaneous autoimmune disease in (NZBxNZW)F1 mice | Q46467101 | ||
| Idiotypic characteristics of immunoglobulins associated with systemic lupus erythematosus. Studies of antibodies deposited in glomeruli of humans | Q46474199 | ||
| Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis. | Q46726702 | ||
| Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. | Q46769274 | ||
| Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy | Q47215436 | ||
| The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis | Q47264616 | ||
| IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice | Q47909571 | ||
| Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus | Q47913418 | ||
| Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice | Q47991495 | ||
| Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus | Q47991818 | ||
| IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus. | Q51074868 | ||
| A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus | Q28254310 | ||
| Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial | Q28304807 | ||
| Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis | Q30449890 | ||
| Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW x BXSB)F1 mice | Q33502266 | ||
| Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus | Q33565963 | ||
| Increased release of von Willebrand factor antigen from endothelial cells by anti-DNA autoantibodies | Q33578658 | ||
| Mesangial cell-binding activity of serum immunoglobulin g in patients with lupus nephritis | Q33875182 | ||
| Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice | Q34080154 | ||
| Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus. | Q34153057 | ||
| Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis | Q34457056 | ||
| Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulin | Q34478786 | ||
| Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus | Q34532672 | ||
| Local Renal Autoantibody Production in Lupus Nephritis | Q34534887 | ||
| Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. | Q34561721 | ||
| Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys | Q34892862 | ||
| In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis | Q35070813 | ||
| IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment | Q35078183 | ||
| Autoreactivity in human IgG+ memory B cells | Q35729131 | ||
| Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice | Q35931319 | ||
| Dysfunctional B cells in systemic lupus erythematosus | Q35952042 | ||
| Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial | Q35993027 | ||
| A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus | Q36369955 | ||
| Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone mice | Q36948466 | ||
| The Characteristics and Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local BAFF Expression | Q36960116 | ||
| Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus | Q37021660 | ||
| The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 | ||
| Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes | Q37426199 | ||
| Biomarkers for lupus nephritis: the quest continues | Q37591664 | ||
| Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche | Q37662690 | ||
| Abnormalities of B cell subsets in patients with systemic lupus erythematosus | Q37769655 | ||
| Epidemiology of systemic lupus erythematosus in Asia | Q37800292 | ||
| Rituximab treatment in lupus nephritis--where do we stand? | Q38095863 | ||
| Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study | Q38466691 | ||
| Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro | Q38968709 | ||
| B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. | Q52032016 | ||
| Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus. | Q53119004 | ||
| Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis. | Q53141150 | ||
| Systemic lupus erythematosus. | Q53495545 | ||
| Accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. | Q53886004 | ||
| Heparin exerts a dual effect on murine lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin binding in glomerular membranes. | Q54395366 | ||
| Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis | Q60729434 | ||
| IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice | Q60998067 | ||
| Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody | Q64389359 | ||
| Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites | Q68013717 | ||
| Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis | Q68918347 | ||
| Common epitopes in Clq and collagen type II | Q69054784 | ||
| Identification of DNA-binding proteins on human umbilical vein endothelial cell plasma membrane | Q70526793 | ||
| Anti-DNA autoantibodies stimulate the release of interleukin-1 and interleukin-6 from endothelial cells | Q71218191 | ||
| Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus | Q71775205 | ||
| Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes | Q72071544 | ||
| Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells | Q72169174 | ||
| Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice | Q72200938 | ||
| Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies | Q72925861 | ||
| IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology | Q73149267 | ||
| Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus | Q73163240 | ||
| Reciprocal regulation of polarized cytokine production by effector B and T cells | Q73256871 | ||
| Effect of anti-DNA autoantibodies on the gene expression of interleukin 8, transforming growth factor-beta, and nitric oxide synthase in cultured endothelial cells | Q74058691 | ||
| Predominance of Th1 immune response in diffuse proliferative lupus nephritis | Q74602869 | ||
| Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus | Q77963967 | ||
| Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus | Q78124722 | ||
| The ananti-alpha-actinin test completes ananti-DNA determination in systemic lupus erythematosus | Q80367271 | ||
| Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus | Q80969796 | ||
| Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1) | Q81512203 | ||
| Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model | Q81893496 | ||
| Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis | Q81973156 | ||
| Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis | Q83226583 | ||
| Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens | Q83228570 | ||
| Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis | Q84080695 | ||
| Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice | Q84523729 | ||
| Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity | Q84580976 | ||
| Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice | Q84737403 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | B-cell | Q188930 |
| pathogenesis | Q372016 | ||
| systemic lupus erythematosus | Q1485 | ||
| autoantibody | Q785022 | ||
| kidney disease | Q1054718 | ||
| helper-inducer T-lymphocytes | Q65983548 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 7917-31 | |
| P577 | publication date | 2015-04-09 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Pathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalities | |
| P478 | volume | 16 |
| Q91612706 | ALW peptide ameliorates lupus nephritis in MRL/lpr mice |
| Q36208980 | Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis |
| Q33753227 | Autoimmune Thyroiditis and Glomerulopathies. |
| Q91964435 | B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments |
| Q47267228 | Clinical & immunological characteristics in systemic lupus erythematosus patients |
| Q37354800 | Concurrent Kimura disease and lupus nephritis: A case report |
| Q36741210 | Correlation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus |
| Q41813911 | Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis |
| Q35871258 | Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases |
| Q89304715 | Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice |
| Q48054830 | Exploring the mechanism of Jieduquyuziyin prescription on systemic lupus erythematosus by GC-MS-based urine metabolomics |
| Q36300008 | Genetics of Lupus Nephritis: Clinical Implications. |
| Q52976160 | Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients. |
| Q55096337 | Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis. |
| Q38649480 | Relevant genetic polymorphisms and kidney expression of Toll-like receptor (TLR)-5 and TLR-9 in lupus nephritis. |
| Q39175811 | T cells and autoimmune kidney disease. |
| Q38771520 | The Increased Expression of Toll-Like Receptor 4 in Renal and Skin Lesions in Lupus Erythematosus |
Search more.